Clindamycin Phosphate; Benzoyl Peroxide Gel — FDA Drug Shortage
The FDA lists a drug shortage record for Clindamycin Phosphate; Benzoyl Peroxide Gel (gel) from Teva Pharmaceuticals USA, Inc. with status No longer listed by FDA. The shortage was first posted on Aug 1, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Teva Pharmaceuticals USA, Inc.
- Package NDC
- 0591-3916-68
- Dosage Form
- Gel
- Presentation
- Clindamycin Phosphate; Benzoyl Peroxide, Gel, 25 mg/1 g; 10 mg/1 g (NDC 0591-3916-68)
- Initial Posting
- Aug 1, 2025